Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Saúde Mental no Distanciamento Social Anonym
Newsletter opened Opened Estratégias motivacionais para combater o estigma Anonym
Newsletter opened Opened Dr. Mattingly discute abordagens durante a pandemia Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
User created User created Anonym
User created User created Anonym
User created User created Anonym
Email verified Email verified Anonym
User created User created Anonym
User created User created Anonym
User created User created Anonym
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonym
User created User created Anonym
User created User created Anonym
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonym
User created User created Anonym
OWA Status Updating trust level from 1 to 2 Anonym
User created User created Anonym
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonym
User created User created Anonym
Newsletter opened Opened Anonym
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonym
OWA Status Check:23517:awatkins1@usc.edu.au:22229ABD-6FA9-93C6-21A9-F2CA955585BE:Updating trust level from [2] to [4] Anonym
OWA Status Check:23515:Jeremy.law@ths.tas.gov.au:39ECD73F-1F81-EE62-C0C5-85F342F54792:Updating trust level from [2] to [4] Anonym
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Saúde Mental no Distanciamento Social Anonym
Newsletter opened Opened Estratégias motivacionais para combater o estigma Anonym
Newsletter opened Opened Dr. Mattingly discute abordagens durante a pandemia Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
User created User created Anonym
User created User created Anonym
User created User created Anonym
Email verified Email verified Anonym
User created User created Anonym
User created User created Anonym
User created User created Anonym
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonym
User created User created Anonym
User created User created Anonym
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonym
User created User created Anonym
OWA Status Updating trust level from 1 to 2 Anonym
User created User created Anonym
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonym
User created User created Anonym
Newsletter opened Opened Anonym
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonym
OWA Status Check:23517:awatkins1@usc.edu.au:22229ABD-6FA9-93C6-21A9-F2CA955585BE:Updating trust level from [2] to [4] Anonym
OWA Status Check:23515:Jeremy.law@ths.tas.gov.au:39ECD73F-1F81-EE62-C0C5-85F342F54792:Updating trust level from [2] to [4] Anonym